Imbalanced host response to SARS-CoV-2 drives development of COVID-19 D Blanco-Melo, BE Nilsson-Payant, WC Liu, S Uhl, D Hoagland, R Møller, ... Cell, 2020 | 4159 | 2020 |
CG dinucleotide suppression enables antiviral defence targeting non-self RNA MA Takata, D Gonçalves-Carneiro, TM Zang, SJ Soll, A York, ... Nature 550 (7674), 124, 2017 | 367 | 2017 |
Conserved and novel miRNAs in the legume Phaseolus vulgaris in response to stress C Arenas-Huertero, B Pérez, F Rabanal, D Blanco-Melo, C De la Rosa, ... Plant molecular biology 70 (4), 385-401, 2009 | 308 | 2009 |
A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics L Si, H Bai, M Rodas, W Cao, CY Oh, A Jiang, R Moller, D Hoagland, ... Nature Biomedical Engineering, 1-15, 2021 | 268 | 2021 |
Global changes in the RNA binding specificity of HIV-1 gag regulate virion genesis SB Kutluay, T Zang, D Blanco-Melo, C Powell, D Jannain, M Errando, ... Cell 159 (5), 1096-1109, 2014 | 265 | 2014 |
SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems D Blanco-Melo, B Nilsson-Payant, WC Liu, R Møller, M Panis, D Sachs, ... BioRxiv, 2020 | 210 | 2020 |
Host and viral determinants of Mx2 antiretroviral activity I Busnadiego, M Kane, SJ Rihn, HF Preugschas, J Hughes, ... Journal of virology 88 (14), 7738-7752, 2014 | 172 | 2014 |
Leveraging the antiviral type-I interferon system as a first line defense against SARS-CoV-2 pathogenicity DA Hoagland, R Møller, SA Uhl, K Oishi, J Frere, I Golynker, S Horiuchi, ... Immunity, 2021 | 162 | 2021 |
Intrinsic cellular defenses against human immunodeficiency viruses D Blanco-Melo, S Venkatesh, PD Bieniasz Immunity 37 (3), 399-411, 2012 | 138 | 2012 |
Recurrent DNA inversion rearrangements in the human genome M Flores, L Morales, C Gonzaga-Jauregui, R Domínguez-Vidaña, ... Proceedings of the National Academy of Sciences 104 (15), 6099-6106, 2007 | 115 | 2007 |
Co-option of an endogenous retrovirus envelope for host defense in hominid ancestors D Blanco-Melo, RJ Gifford, PD Bieniasz Elife 6, e22519, 2017 | 90 | 2017 |
The NF-κB transcriptional footprint is essential for SARS-CoV-2 replication BE Nilsson-Payant, S Uhl, A Grimont, AS Doane, P Cohen, RS Patel, ... Journal of Virology, JVI. 01257-21, 2021 | 78 | 2021 |
The decline of human endogenous retroviruses: extinction and survival G Magiorkinis, D Blanco-Melo, R Belshaw Retrovirology 12 (1), 8, 2015 | 64 | 2015 |
RNase III nucleases from diverse kingdoms serve as antiviral effectors LC Aguado, S Schmid, J May, LR Sabin, M Panis, D Blanco-Melo, ... Nature 547 (7661), 114, 2017 | 59 | 2017 |
Type I interferon response impairs differentiation potential of pluripotent stem cells J Eggenberger, D Blanco-Melo, M Panis, KJ Brennand Proceedings of the National Academy of Sciences 116 (4), 1384-1393, 2019 | 52 | 2019 |
Global synonymous mutagenesis identifies cis-acting RNA elements that regulate HIV-1 splicing and replication M Takata, SJ Soll, A Emery, D Blanco-Melo, R Swanstrom, PD Bieniasz PLoS pathogens 14 (1), e1006824, 2018 | 44 | 2018 |
Origins and Evolution of tetherin, an Orphan Antiviral Gene D Blanco-Melo, S Venkatesh, PD Bieniasz Cell Host & Microbe 20 (2), 189-201, 2016 | 33 | 2016 |
Ancient viral genomes reveal introduction of human pathogenic viruses into Mexico during the transatlantic slave trade AA Guzmán-Solís, V Villa-Islas, MJ Bravo-López, M Sandoval-Velasco, ... Elife 10, e68612, 2021 | 28 | 2021 |
Reduced Nucleoprotein availability impairs negative-sense RNA virus replication and promotes host recognition BE Nilsson-Payant, D Blanco-Melo, S Uhl, B Escudero-Pérez, ... Journal of Virology, 2021 | 28 | 2021 |
Human organ chip-enabled pipeline to rapidly repurpose therapeutics during viral pandemics L Si, H Bai, M Rodas, W Cao, CY Oh, A Jiang, R Moller, D Hoagland, ... bioRxiv, 2020 | 27 | 2020 |